ClinicalTrials.gg
RecruitingNCT07265154Updated Aug 18, 2026

Gait Training and Balance Using Artificial Intelligence

An interventional study of Artificial Intelligence in Above Knee Amputation and Amputation, sponsored by South Valley University. Recruiting at 1 site in Egypt. Open to participants aged 16 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-08-18.

Sponsored by South Valley University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Jun 2026; still recruiting 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
16 Years to 50 Years
Sex
All
01

Study summary

Effect of Using Artificial Intelligence on Gait Training and Balance in Above Knee Amputation Patients

02

Conditions studied

  • Above Knee Amputation
  • Amputation

Keywords

  • Amputation
  • Above Knee Amputation
  • Artificial Intelligence
  • Gait training
  • Balance
03

In context

Lead sponsor

South Valley University is the lead sponsor of 153 studies on the registry; 46 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All patients have above-knee amputations.
  • All patients have no other neurological diseases affecting gait.
  • All patients have no other neurological diseases affecting muscle balance.
  • All patients have no other complications affecting joint ROM.

Exclusion criteria

Exclusion Criteria:

  • Patients have any complications affecting joint ROM.
  • Patients have any neurological condition affecting muscle balance.
  • Patients have any neurological condition affecting gait.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    group A

    Gait and Balance Training Using Artificial Intelligence

    Device: Artificial Intelligence

  • No intervention
    group B

    Traditional Physical Therapy Program

Interventions

  • DeviceArtificial Intelligence

    using artificial intelligence in gait and balance training for above knee amputee

06

What researchers measure

Primary outcomes

  1. Medio-lateral Stability Index (MLSI)

    Medio-lateral Stability Index (MLSI) represents fluctuations from the horizontal around the mediolateral axis

    Time frame: Day 0, Day 90

  2. Anterior-posterior Stability Index (APSI)

    Anterior-posterior Stability Index (APSI) represents fluctuations from the horizontal around the anteroposterior axis

    Time frame: Day 0, Day 90

  3. Overall Stability Index (OSI)

    Overall Stability Index (OSI) a composite of MLSI and APSI so it is sensitive to changes in both directions

    Time frame: Day 0, Day 90

07

Study locations

1 of 1 sites recruiting
  • Faculty of Physical Therapy,
    Banhā, Benha 83523, Egypt
    Recruiting
    • Mohammed Ali, PhD · Contactm.essam@svu.edu.eg · 01011212425
    • · Contactm.essam@svu.edu.eg
    • Mohammed E. Ali, PhD · Principal investigator
    • Nehad A. Abo-zaid, PhD · Principal investigator
08

References and documents

Publications

  • Hartley H, Cassidy E, Bunn L, Kumar R, Pizer B, Lane S, Carter B. Exercise and Physical Therapy Interventions for Children with Ataxia: A Systematic Review. Cerebellum. 2019 Oct;18(5):951-968. doi: 10.1007/s12311-019-01063-z. PubMed 31392562 ↗
  • Tatla SK, Radomski A, Cheung J, Maron M, Jarus T. Wii-habilitation as balance therapy for children with acquired brain injury. Dev Neurorehabil. 2014 Feb;17(1):1-15. doi: 10.3109/17518423.2012.740508. Epub 2012 Dec 11. PubMed 23231377 ↗
  • 1. Nehad A. Abo-Zaid, Nesma A Helmy, Nader I Elsayed, Amira H Mohammed. Wii Sport versus task-oriented training on gait in unilateral cerebral palsy: A randomized controlled trial. Conference: Journal of Human Sport and Exercise. Autumn Conferences of Sports Science2021.16. Proc2.36, doi: 10.14198/jhse.
  • Abo-Zaid NA, El-Gendy AM, Hewidy I, Essam Ali M, Sabbahi A. Influence of aerobic exercise on inhibitory control of executive functions in children with hemiplegic cerebral palsy: A randomized controlled trial. Clin Rehabil. 2024 Mar;38(3):337-346. doi: 10.1177/02692155231208578. Epub 2023 Oct 26. PubMed 37885221 ↗
  • 27. Nehad A Abo-zaid, Hebatallah M Zaghloul, Heba A Khalifa., Mohammed E Ali, Mohamed Y Abdelsamee. Efficacy of Lower Extremity Mirror Therapy on Balance in Children with Hemiplegic Cerebral Palsy: A Randomized Controlled Trial International Journal of Psychosocial Rehabilitation, 2020, Vol. 24, Issue 08
  • Nolan L, Grigorenko A, Thorstensson A. Balance control: sex and age differences in 9- to 16-year-olds. Dev Med Child Neurol. 2005 Jul;47(7):449-54. doi: 10.1017/s0012162205000873. PubMed 15991864 ↗
  • Kitago T, Krakauer JW. Motor learning principles for neurorehabilitation. Handb Clin Neurol. 2013;110:93-103. doi: 10.1016/B978-0-444-52901-5.00008-3. PubMed 23312633 ↗
  • Dewar R, Love S, Johnston LM. Exercise interventions improve postural control in children with cerebral palsy: a systematic review. Dev Med Child Neurol. 2015 Jun;57(6):504-20. doi: 10.1111/dmcn.12660. Epub 2014 Dec 18. PubMed 25523410 ↗
  • 45. Rafaela Ribeiro da Silva, Cristina Iwabe-Marchese. Using virtual reality for motor rehabilitation in a child with ataxic cerebral palsy: case report. Fisioter Pesq. 2015; 22(1):97-102, doi.org/10.590/1809-2950/13375322012015

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2026 (actual). Primary completion is estimated for Sep 2026, 3 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 23, 2025
First posted
Dec 4, 2025
StartActual
Jun 1, 2026
Primary completionEst.
Sep 1, 2026
CompletionEst.
Sep 30, 2026
Last update
Aug 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07265154
Collaborators
Badr University, Benha University, Al Salam University
Responsible party
Mohammed E. Ali (Lecturer of Physical Therapy, South Valley University) — Principal investigator
First posted
Dec 4, 2025
Start date
Jun 1, 2026
Primary completion
Sep 1, 2026 (estimated)
Completion
Sep 30, 2026 (estimated)
Last update
Aug 18, 2026

Study contacts

Mohammed E. Ali, PhD
Contact
m.essam@svu.edu.eg
+201011212425

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion